DeutschNewstral
Article
bizjournals.com on 2017-08-25 17:59
Rockville biotech buys Cambridge gene therapy firm for $86M
Related news
Regenxbio opens gene therapy manufacturing facility in Rockvillethedailyrecord.com- Cambridge biotech Sarepta tops $11B market cap on gene therapy databizjournals.com
- Cambridge biotech developing cystic fibrosis drug seeks $86M IPObizjournals.com
- German firm that serves gene therapy biotechs opens Cambridge HQbizjournals.com
- Consultant to Cambridge gene therapy firm charged with insider tradingbizjournals.com
- Cambridge gene therapy firm bluebird bio to move to Somervillebizjournals.com
- Lexington biotech plots $86M IPO as key gene therapy trial nearsbizjournals.com
- New Cambridge biotech Korro aims to develop a reversible form of gene editingbizjournals.com
- Cambridge gene therapy firm loses half of market cap on study resultsbizjournals.com
- After bidding war, Cambridge gene therapy firm Dimension accepts $151M buyoutbizjournals.com
- Cambridge gene therapy company aims to raise $83M in an IPO next weekbizjournals.com
- Rockville biotech Vigene to acquire Omnia Biologicsthedailyrecord.com
- Rockville biotech looks for lifeline following restructuringbizjournals.com
- Berkeley cancer therapy startup Aduro Biotech seeks $86M in IPObizjournals.com
- Gene therapy company Audentes shoots for $86M IPObizjournals.com
- Rockville biotech founded by L.A. billionaire to lay off 52bizjournals.com
- Rockville biotech raising $7.5M for new manufacturing facilitybizjournals.com
- Rockville biotech plans another expansion in Montgomery Countybizjournals.com
- Cambridge biotech delivers coronavirus vaccinebizjournals.com
- Venture-backed Rockville biotech firm files for IPObizjournals.com